المؤلفون: Rücker FG; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Corbacioglu A; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Krzykalla J; Division of Biostatistics German Cancer Research Center Heidelberg Germany., Cocciardi S; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Lengerke C; Medical Clinic, Department of Hematology, Oncology, Clinical Immunology and Rheumatology University Hospital Tübingen Tübingen Germany., Germing U; Department of Hematology, Oncology and Clinical Immunology Heinrich Heine University Düsseldorf Germany., Wulf G; Department of Hematology and Medical Oncology University Medical Center Göttingen Göttingen Germany., Samra MA; Department of Internal Medicine IV University Hospital of Gießen Gießen Germany., Teichmann LL; Department of Medicine and Polyclinic III Bonn University Hospital Bonn Germany., Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation University of Freiburg Medical Center Freiburg Germany., Kühn MWM; Department of Hematology and Oncology University Medical Center Mainz Mainz Germany., Bentz M; Department of Internal Medicine III Hospital of Karlsruhe Karlsruhe Germany., Westermann J; Department of Hematology, Oncology and Tumor Immunology Charité University Medicine Berlin Germany., Bullinger L; Department of Hematology, Oncology and Tumor Immunology Charité University Medicine Berlin Germany., Gaidzik VI; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Meid A; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Aicher S; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Stegelmann F; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Weber D; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Schrade A; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany., Benner A; Division of Biostatistics German Cancer Research Center Heidelberg Germany., Döhner H; Department of Internal Medicine III University Hospital of Ulm Ulm Germany., Döhner K; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.

مؤلفون مشاركون: German‐Austrian Acute Myeloid Leukemia Study Group (AMLSG)

المصدر: HemaSphere [Hemasphere] 2024 Jul 15; Vol. 8 (7), pp. e123. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Kühn MWM; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

المصدر: British journal of haematology [Br J Haematol] 2024 May 06. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

المؤلفون: Tubío-Santamaría N; Innere Medizin C, Universitätsmedizin Greifswald, 17475, Greifswald, Germany.; Leibniz Institute On Aging, Fritz-Lipmann Institute, 07745, Jena, Germany., Jayavelu AK; Max-Planck-Institute of Biochemistry, Munich, Germany.; Proteomics and Cancer Cell Signaling Group, DKFZ, Heidelberg, Germany., Schnoeder TM; Innere Medizin C, Universitätsmedizin Greifswald, 17475, Greifswald, Germany.; Leibniz Institute On Aging, Fritz-Lipmann Institute, 07745, Jena, Germany., Eifert T; Innere Medizin C, Universitätsmedizin Greifswald, 17475, Greifswald, Germany.; Leibniz Institute On Aging, Fritz-Lipmann Institute, 07745, Jena, Germany., Hsu CJ; Innere Medizin C, Universitätsmedizin Greifswald, 17475, Greifswald, Germany.; Leibniz Institute On Aging, Fritz-Lipmann Institute, 07745, Jena, Germany., Perner F; Innere Medizin C, Universitätsmedizin Greifswald, 17475, Greifswald, Germany., Zhang Q; Innere Medizin C, Universitätsmedizin Greifswald, 17475, Greifswald, Germany., Wenge DV; Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard University, Boston, MA, 02215, USA., Hansen FM; Max-Planck-Institute of Biochemistry, Munich, Germany., Kirkpatrick JM; Independent consultant, London, UK., Jyotsana N; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA., Lane SW; Queensland Institute for Medical Research (QIMR), Brisbane, Australia., von Eyss B; Leibniz Institute On Aging, Fritz-Lipmann Institute, 07745, Jena, Germany., Deshpande AJ; Sanford Burnham Research Institute, San Diego, USA., Kühn MWM; Medizinische Klinik 3, Hämatologie, Onkologie und Pneumologie, Universitätsmedizin Mainz, Mainz, Germany., Schwaller J; Department of Biomedicine, University Children's Hospital of Basel, Basel, Switzerland., Cammann C; Friedrich Loeffler-Institut für Medizinische Mikrobiologie - Virologie, Universitätsmedizin Greifswald, 17475, Greifswald, Germany., Seifert U; Friedrich Loeffler-Institut für Medizinische Mikrobiologie - Virologie, Universitätsmedizin Greifswald, 17475, Greifswald, Germany., Ebstein F; Department of Biochemistry, Universitätsmedizin Greifswald, 17475, Greifswald, Germany., Krüger E; Department of Biochemistry, Universitätsmedizin Greifswald, 17475, Greifswald, Germany., Hochhaus A; Innere Medizin 2, Universitätsklinikum Jena, Jena, Germany., Heuser M; Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany., Ori A; Leibniz Institute On Aging, Fritz-Lipmann Institute, 07745, Jena, Germany., Mann M; Max-Planck-Institute of Biochemistry, Munich, Germany., Armstrong SA; Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard University, Boston, MA, 02215, USA., Heidel FH; Innere Medizin C, Universitätsmedizin Greifswald, 17475, Greifswald, Germany. heidel.florian@mh-hannover.de.; Leibniz Institute On Aging, Fritz-Lipmann Institute, 07745, Jena, Germany. heidel.florian@mh-hannover.de.; Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany. heidel.florian@mh-hannover.de.

المصدر: Molecular cancer [Mol Cancer] 2023 Dec 04; Vol. 22 (1), pp. 196. Date of Electronic Publication: 2023 Dec 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Proteomics* , Leukemia, Myeloid, Acute*/metabolism, Humans ; Mice ; Animals ; Myeloid-Lymphoid Leukemia Protein/genetics ; Myeloid-Lymphoid Leukemia Protein/metabolism ; Transcription Factors/genetics ; Mutation ; Gene Expression

المؤلفون: Rausch J; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Dzama MM; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz., Dolgikh N; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Stiller HL; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Bohl SR; Department of Medical Oncology, Dana- Farber Cancer Institute, Boston, MA., Lahrmann C; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Kunz K; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Kessler L; Kura Oncology Inc., San Diego, CA 92130., Echchannaoui H; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Chen CW; Department of Systems Biology, Beckman Research Institute City of Hope, Duarte, CA., Kindler T; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Döhner K; Department of Internal Medicine III, Ulm University Hospital, Ulm., Burrows F; Kura Oncology Inc., San Diego, CA 92130., Theobald M; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Sasca D; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz., Kühn MWM; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz. mickuehn@uni-mainz.de.

المصدر: Haematologica [Haematologica] 2023 Oct 01; Vol. 108 (10), pp. 2837-2843. Date of Electronic Publication: 2023 Oct 01.

نوع المنشور: Letter; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Chromatin* , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Myeloid-Lymphoid Leukemia Protein/genetics ; Nuclear Proteins/genetics ; Mutation ; Apoptosis

المؤلفون: Rausch J; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.; German Cancer Consortium (DKTK) Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany., Ullrich E; German Cancer Consortium (DKTK) Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Children's Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; University Cancer Center (UCT), Frankfurt, Germany., Kühn MWM; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.; German Cancer Consortium (DKTK) Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany.

المصدر: Frontiers in immunology [Front Immunol] 2023 Sep 22; Vol. 14, pp. 1269012. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Immunotherapy ; Azacitidine/therapeutic use ; Treatment Outcome ; Epigenesis, Genetic

المؤلفون: Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany. Electronic address: hartmut.doehner@uniklinik-ulm.de., Weber D; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Fiedler W; Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Kühn MWM; Department of Hematology, Medical Oncology & Pneumology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany., Schroeder T; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Mayer K; Department of Hematology, Oncology, University Hospital Bonn, Bonn, Germany., Lübbert M; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Wattad M; Klinik für Hämatologie, Internistische Onkologie & Stammzelltransplantation, Evang. Krankenhaus Essen-Werden, Essen-Werden, Germany; Klinikum Hochsauerland, Meschede, Germany., Götze K; Department of Medicine III, Hematology and Medical Oncology, Technical University of Munich, Munich, Germany., Fransecky L; Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Koller E; Department of Internal Medicine III, Hanusch Krankenhaus Wien, Wien, Austria., Wulf G; Department of Hematology and Medical Oncology, University Medicine Göttingen, Göttingen, Germany., Schleicher J; Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin, Klinikum Stuttgart, Stuttgart, Germany., Ringhoffer M; Department of Internal Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany., Greil R; 3rd Medical Department Paracelsus Medical University Salzburg, Salzburg, Austria; Salzburg Cancer Research Institute Center for Clinical Trials and Immunology Trials, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria., Hertenstein B; Department of Hematology and Oncology, Klinikum Bremen-Mitte, Bremen, Germany., Krauter J; Medizinische Klinik III, Städtisches Klinikum Braunschweig, Braunschweig, Germany., Martens UM; Klinik für Innere Medizin III, SLK-Kliniken Heilbronn, Heilbronn, Germany., Nachbaur D; Universitätsklinik für Innere Medizin V, Medizinische Universität Innsbruck, Innsbruck, Austria., Samra MA; Medizinische Klinik IV, Universitätsklinikum Gießen, Gießen, Germany., Machherndl-Spandl S; Department of Hematology and Oncology, Ordensklinikum Elisabethinen Linz, Linz, Austria., Basara N; Medizinische Klinik I, Malteser Krankenhaus St Franziskus-Hospital Flensburg, Flensburg, Germany., Leis C; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Schrade A; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Kapp-Schwoerer S; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Cocciardi S; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Paschka P; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Gaidzik VI; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Saadati M; Freelance Statistician, Saadati Solutions, Ladenburg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Schlenk RF; National Center of Tumor Diseases, German Cancer Research Center, Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Döhner K; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

مؤلفون مشاركون: German–Austrian AML Study Group

المصدر: The Lancet. Haematology [Lancet Haematol] 2023 Jul; Vol. 10 (7), pp. e495-e509. Date of Electronic Publication: 2023 May 12.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/diagnosis , Neoplasm Recurrence, Local*/drug therapy, Adolescent ; Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cytarabine/therapeutic use ; Gemtuzumab/therapeutic use ; Nuclear Proteins/genetics ; Treatment Outcome ; Tretinoin/therapeutic use

المؤلفون: Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Fiedler W; Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Wulf G; Department of Hematology and Oncology, Georg-August-University Göttingen, Göttingen, Germany., Salih H; Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany., Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Kühn MWM; Department of Hematology, Medical Oncology & Pneumology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany., Schroeder T; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Salwender H; Department of Oncology and Hematology, Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Götze K; Department of Medicine III, Hematology and Medical Oncology, Technical University of Munich, Munich, Germany., Westermann J; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Fransecky L; Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Mayer K; Department of Hematology, Oncology, University Hospital Bonn, Bonn, Germany., Hertenstein B; Department of Hematology and Oncology, Klinikum Bremen-Mitte, Bremen, Germany., Ringhoffer M; Department of Internal Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany., Tischler HJ; Department of Hematology and Oncology, University Hospital of Minden, Minden, Germany., Machherndl-Spandl S; Department of Hematology and Oncology, Hospital Elisabethinen Linz, Linz, Austria., Schrade A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Theis F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Schlenk RF; National Center of Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Bullinger L; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Saadati M; Freelance Statistician, Saadati Solutions, Ladenburg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Larson R; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL; and., Stone R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

المصدر: Blood advances [Blood Adv] 2022 Sep 27; Vol. 6 (18), pp. 5345-5355.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/methods , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Adolescent ; Adult ; Aged ; Humans ; Middle Aged ; Protein-Tyrosine Kinases ; Staurosporine/adverse effects ; Staurosporine/analogs & derivatives ; Young Adult ; fms-Like Tyrosine Kinase 3/genetics ; fms-Like Tyrosine Kinase 3/therapeutic use

المؤلفون: Albinger N; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany., Pfeifer R; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Nitsche M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Mertlitz S; Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany., Campe J; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany., Stein K; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany., Kreyenberg H; Division for Stem Cell Transplantation, Immunology, and Intensive Care Medicine, Department for Children and Adolescents, University Hospital, Johann Wolfgang Goethe University, Frankfurt am Main, Germany., Schubert R; Childrens Hospital, Pulmology and Allergology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany., Quadflieg M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Schneider D; Lentigen Technology, Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA., Kühn MWM; Department of Hematology, Medical Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University, Mainz, Germany., Penack O; Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany., Zhang C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Möker N; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Ullrich E; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. Evelyn.Ullrich@kgu.de.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. Evelyn.Ullrich@kgu.de.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany. Evelyn.Ullrich@kgu.de.; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany. Evelyn.Ullrich@kgu.de.

المصدر: Blood cancer journal [Blood Cancer J] 2022 Apr 13; Vol. 12 (4), pp. 61. Date of Electronic Publication: 2022 Apr 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Killer Cells, Natural* , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy, Animals ; Cell Line, Tumor ; Disease Models, Animal ; Hematopoiesis ; Humans ; Immunotherapy, Adoptive ; Mice ; Sialic Acid Binding Ig-like Lectin 3/genetics

المؤلفون: Teich K; Department of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Krzykalla J; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg., Kapp-Schwoerer S; Department of Internal Medicine III, University Hospital of Ulm, Ulm., Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm., Schlenk RF; Nationales Centrum für Tumorerkrankungen Trial Center, National Center of Tumor Diseases, German Cancer Research Center, Heidelberg; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg., Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm., Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm., Fiedler W; Department of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg., Kühn MWM; Department of Hematology, Medical Oncology and Pneumology, University Medical Center Mainz, Mainz., Schroeder T; Department of Hematology, Oncology, and Clinical Immunology, University of Düsseldorf, Medical Faculty, Düsseldorf., Mayer K; Internal Medicine III, University Hospital of Bonn, Bonn., Lübbert M; Klinik für Innere Medizin I, Universitätsklinikum Freiburg, Faculty of Medicine, Freiburg., Ramachandran D; Department Molecular Gynecology, Hannover Medical School, Hannover., Benner A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg., Ganser A; Department of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm., Heuser M; Department of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm., Thol F; Department of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover.

المصدر: Haematologica [Haematologica] 2021 Nov 01; Vol. 106 (11), pp. 2986-2989. Date of Electronic Publication: 2021 Nov 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Polymorphism, Single Nucleotide*, Aminoglycosides/therapeutic use ; Gemtuzumab ; Humans ; Sialic Acid Binding Ig-like Lectin 3/genetics

المؤلفون: Sasca D; Department of Hematology, Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University Mainz, Mainz., Guezguez B; Department of Hematology, Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University Mainz, Mainz.; German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Mainz, Germany., Kühn MWM; Department of Hematology, Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University Mainz, Mainz.

المصدر: Current opinion in hematology [Curr Opin Hematol] 2021 Sep 01; Vol. 28 (5), pp. 356-363.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Lippincott Williams And Wilkins Country of Publication: United States NLM ID: 9430802 Publication Model: Print Cited Medium: Internet ISSN: 1531-7048 (Electronic) Linking ISSN: 10656251 NLM ISO Abbreviation: Curr Opin Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms*/drug therapy , Hematologic Neoplasms*/genetics , Hematologic Neoplasms*/metabolism , Myeloproliferative Disorders*/drug therapy , Myeloproliferative Disorders*/genetics , Myeloproliferative Disorders*/metabolism, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Epigenesis, Genetic/*drug effects , Gene Expression Regulation, Neoplastic/*drug effects , Transcription, Genetic/*drug effects, Humans ; Nucleosomes/genetics ; Nucleosomes/metabolism